Kadimastem Stock EBITDA
| KDST Stock | ILA 1,189 14.00 1.19% |
Kadimastem fundamentals help investors to digest information that contributes to Kadimastem's financial success or failures. It also enables traders to predict the movement of Kadimastem Stock. The fundamental analysis module provides a way to measure Kadimastem's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kadimastem stock.
Kadimastem |
Kadimastem Company EBITDA Analysis
Kadimastem's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Kadimastem EBITDA | (24.48 M) |
Most of Kadimastem's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kadimastem is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Kadimastem reported earnings before interest,tax, depreciation and amortization of (24.48 Million). This is 102.79% lower than that of the Biotechnology sector and 124.44% lower than that of the Health Care industry. The ebitda for all Israel stocks is 100.63% higher than that of the company.
Kadimastem EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kadimastem's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kadimastem could also be used in its relative valuation, which is a method of valuing Kadimastem by comparing valuation metrics of similar companies.Kadimastem is currently under evaluation in ebitda category among its peers.
Kadimastem Fundamentals
| Return On Equity | -7.35 | |||
| Return On Asset | -0.75 | |||
| Current Valuation | 38.77 M | |||
| Shares Outstanding | 35.76 M | |||
| Shares Owned By Insiders | 53.72 % | |||
| Shares Owned By Institutions | 8.31 % | |||
| Price To Earning | (167.60) X | |||
| Price To Book | 5.90 X | |||
| EBITDA | (24.48 M) | |||
| Net Income | (26.27 M) | |||
| Cash And Equivalents | 5.43 M | |||
| Cash Per Share | 0.28 X | |||
| Total Debt | 12.96 M | |||
| Debt To Equity | 7.80 % | |||
| Current Ratio | 0.39 X | |||
| Book Value Per Share | 0.23 X | |||
| Cash Flow From Operations | (21.55 M) | |||
| Earnings Per Share | (1.11) X | |||
| Number Of Employees | 23 | |||
| Beta | 0.69 | |||
| Market Capitalization | 30.32 M | |||
| Total Asset | 27.34 M | |||
| Retained Earnings | (88 M) | |||
| Working Capital | (6 M) | |||
| Current Asset | 5 M | |||
| Current Liabilities | 11 M | |||
| Z Score | -3.0 | |||
| Net Asset | 27.34 M |
About Kadimastem Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kadimastem's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kadimastem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kadimastem based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Kadimastem Stock
Kadimastem financial ratios help investors to determine whether Kadimastem Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kadimastem with respect to the benefits of owning Kadimastem security.